Rare manufacturing glitch raises concern over CAR-T therapies: study

A single leukemia cell inadvertently got mixed in with a batch of a patient's immune cells that were being manufactured into a CAR-T cell therapy and it acquired resistance to the treatment with deadly results, University of Pennsylvania researchers reported on Monday.

Philip Morris sues South Korea over e-cigarette info disclosure

Philip Morris Korea Inc. said on Monday it has filed a lawsuit against the South Korean government, demanding the disclosure of information on a recent test that concluded electronic cigarettes contain harmful substances.

Antares Pharma's testosterone drug gets FDA approval

The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's drug to treat low testosterone levels in men, the company said, nearly a year after rejecting the injection.